Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals

Frontiers in Cardiovascular Medicine

Cardiovascular Medicine

Antonella Moreo¹  Giuseppina Gallucci²  Fabrizio Oliva³  Fabiana Lucà⁴  Fabio Maria Turazza⁵  Raffaella Mistrulli⁶  Chiara Lestuzzi⁷  Stefania Angela Di Fusco⁸  Furio Colivicchi⁸  Vincenzo Quagliariello⁹  Nicola Maurea⁹  Andrea Paccone⁹  Iris Parrini^1,10  Massimiliano Camilli^1,11  Vito Racanelli^1,12  Andrea Camerini^1,13  Giuseppe Curigliano^1,14  Fabio Calabrò^1,15  Alessandro Inno^1,16  Antonio Russo^1,17  Lorena Incorvaia^1,17  Maria Laura Canale^1,18  Leonardo De Luca^1,19  Domenico Gabrielli^2,20  Luigi Tarantini^2,21  Irma Bisceglia^2,22  Saverio Cinieri^2,23  Giulia Russo^2,24  Damiana Fiscella^2,25  Michele Massimo Gulizia^2,25  Stefano Oliva^2,26  Nicola Silvestris^2,27  Giuseppina Rosaria Ricciardi^2,28 

[1] Cardio Center De Gasperis, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy;Cardio-oncology Unit, Department of OncoHaematology, IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy;Cardiologia 1- Emodinamica, Dipartimento Cardiotoracovascolare “A. De Gasperis”, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy;Cardiologia Interventistica, Utic, Grande Ospedale Metropolitano, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy;Cardiology Department, National Cancer Institute Foundation (IRCCS), Milan, Italy;Cardiology Unit, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Lazio, Italy;Centro Medico Esperia, Porcia (PN), Italy;Clinical and Rehabilitation Cardiology Unit, San Filippo Neri Hospital, ASL Roma 1, Rome, Italy;Department of Cardiology, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy;Department of Cardiology, Hospital Mauritian Turin, Turin, Italy;Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart and Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;Department of Interdisciplinary Medicine, School of Medicine, University of Bari Aldo Moro, Bari, Italy;Department of Medical Oncology, Ospedale Versilia, Azienda Usl Toscana Nord Ovest, Lido di Camaiore, Italy;Department of Oncology and Hemato-Oncology, University of Milan; Division of Early Drug Development, Istituto Europeo di Oncologia, IRCCS, Milan, Italy;Department of Oncology and Specialized Medicine, San Camillo-Forlanini Hospital, Rome, Italy;Department of Oncology, Sacro Cuore Don Calabria Hospital (IRCCS), Negrar, Italy;Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, Palermo University Hospital, Palermo, Italy;Division of Cardiology, Ospedale Versilia, Azienda Usl Toscana Nord Ovest, Lido di Camaiore, Italy;Division of Cardiology, San Camillo-Forlanini Hospital, Rome, Italy;Division of Cardiology, San Camillo-Forlanini Hospital, Rome, Italy;Division of Cardiology, San Camillo-Forlanini Hospital, Rome, Italy;Divisione di Cardiologia, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS di Reggio-Emilia, Reggio Emilia, Italy;Integrated Cardiology Services, Cardio-Thoracic-Vascular Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy;Medical Oncology Division and Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, Brindisi, Italy;SC Patologie Cardiovascolari, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy;U.O.C. Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione “Garibaldi”, Catania, Italy;UOSD Cardiologia di Interesse Oncologico, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy;Unit of Medical Oncology, Department of Human Pathology in Adulthood and Childhood Gaetano Barresi, University of Messina, Messina, Italy;Unit of Medical Oncology, Papardo Hospital, Messina, Italy;

关键词: cancer survivors (CSs);    cardiovascular disease (CVD);    cancer therapy-related cardiovascular toxicities (CTR-CVT);    cardiovascular risk factors (CVRF);    reverse cardio-oncology;    survivorship care;   

DOI  :  10.3389/fcvm.2023.1223660

 received in 2023-05-16, accepted in 2023-08-24,  发布年份 2023

来源: Frontiers

【 摘 要 】

In cancer, a patient is considered a survivor from the time of initial diagnosis until the end of life. With improvements in early diagnosis and treatment, the number of cancer survivors (CS) has grown considerably and includes: (1) Patients cured and free from cancer who may be at risk of late-onset cancer therapy-related cardiovascular toxicity (CTR-CVT); (2) Patients with long-term control of not-curable cancers in whom CTR-CVT may need to be addressed. This paper highlights the importance of the cancer care continuum, of a patient-centered approach and of a prevention-oriented policy. The ultimate goal is a personalized care of CS, achievable only through a multidisciplinary-guided survivorship care plan, one that replaces the fragmented management of current healthcare systems. Collaboration between oncologists and cardiologists is the pillar of a framework in which primary care providers and other specialists must be engaged and in which familial, social and environmental factors are also taken into account.

【 授权许可】

Unknown   
© 2023 Bisceglia, Canale, Silvestris, Gallucci, Camerini, Inno, Camilli, Turazza, Russo, Paccone, Mistrulli, De Luca, Di Fusco, Tarantini, Lucà, Oliva, Moreo, Maurea, Quagliariello, Ricciardi, Lestuzzi, Fiscella, Parrini, Racanelli, Russo, Incorvaia, Calabrò, Curigliano, Cinieri, Gulizia, Gabrielli, Oliva and Colivicchi.